Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06309602 · ClinicalTrials.gov registry record · NA
Investigation of a Free Water Protocol
A NA study of Oropharyngeal Dysphagia, sponsored by Poudre Valley Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 136
- Enrollment target
- 2
- Study locations
NCT06309602: Recruiting NA study of Oropharyngeal Dysphagia, sponsored by Poudre Valley Health System.
NCT06309602 is a NA study of Oropharyngeal Dysphagia that is actively recruiting participants, run by Poudre Valley Health System. The registered enrollment target is 136 participants, above the 91-participant average among 7 other Oropharyngeal Dysphagia trials with a reported enrollment target (49% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06309602, a NA study of Oropharyngeal Dysphagia, is actively recruiting participants, sponsored by Poudre Valley Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
- 2
- Study locations
Study Summary
Hypothesis: Use of a Free Water Protocol (FWP) will improve patient satisfaction scores (Dysphagia Handicap Index), will not increase the risk of aspiration pneumonia/pneumonitis, and will result in improved oral hygiene (as assessed by the Oral Assessment Guide). Aim: To demonstrate that improvement in patient satisfaction and quality of life scores outweighs the potential risks of aspiration of plain water in an acute care setting; to qualitatively assess the implementation of a Free Water Protocol from the viewpoints of the patient and family/caregivers; to quantify changes in oral hygiene practices for individuals on the Free Water Protocol.
Primary Outcome
Quality of life survey
Conditions Studied
Interventions
- OTHER Free Water Protocol
- OTHER Control / Standard Care
Study Locations (2)
Colorado
- Medical Center of the Rockies - Loveland
- Medical Center of the Rockies - Loveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2024-10-22 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
What NCT06309602 shows while recruiting
NCT06309602 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, above the 91-participant average among 7 other Oropharyngeal Dysphagia trials with a reported enrollment target (49% higher).
The record links to 1 condition, with Oropharyngeal Dysphagia appearing as the primary indexed condition, and to 2 interventions - of which Free Water Protocol is the first listed.
NCT06309602 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06309602 about?
NCT06309602 is a clinical study titled "Investigation of a Free Water Protocol". Hypothesis: Use of a Free Water Protocol (FWP) will improve patient satisfaction scores (Dysphagia Handicap Index), will not increase the risk of aspiration pneumonia/pneumonitis, and will result in improved oral hygiene (as assessed by the Oral Assessment Guide). Aim: To demonstrate that improvemen...
What is the current status of trial NCT06309602?
This trial is currently recruiting. It is a NA study. The enrollment target is 136 participants. The study started on 2024-10-22. Estimated completion is 2028-01-01.
What conditions does trial NCT06309602 study?
This clinical trial studies the following conditions: Oropharyngeal Dysphagia.
What interventions are being tested in trial NCT06309602?
The interventions under investigation include: Free Water Protocol (OTHER), Control / Standard Care (OTHER).
Who is sponsoring clinical trial NCT06309602?
This trial is sponsored by Poudre Valley Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06309602 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oropharyngeal Dysphagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Training Swallowing Initiation During Expiration
RECRUITING · NA
-
Utilization of Negative Pressure Suction to Reduce Aspiration in Oropharyngeal Dysphagia
RECRUITING · NA
-
Oral and Swallowing Function in Older Adults
RECRUITING
-
Effect of Thickened Feeds on Clinical Outcomes in Children With Brief Resolved Unexplained Event
RECRUITING
-
Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia
ACTIVE NOT RECRUITING · Phase 1
-
Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI